These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 27074368)

  • 1. Evaluation of the safety and tolerability of rivaroxaban in dogs with presumed primary immune-mediated hemolytic anemia.
    Morassi A; Bianco D; Park E; Nakamura RK; White GA
    J Vet Emerg Crit Care (San Antonio); 2016 Jul; 26(4):488-94. PubMed ID: 27074368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective study of clopidogrel therapy in dogs with primary immune-mediated hemolytic anemia.
    Mellett AM; Nakamura RK; Bianco D
    J Vet Intern Med; 2011; 25(1):71-5. PubMed ID: 21155892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of enoxaparin in dogs with primary immune-mediated hemolytic anemia: 21 cases.
    Panek CM; Nakamura RK; Bianco D
    J Vet Emerg Crit Care (San Antonio); 2015; 25(2):273-7. PubMed ID: 25773906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of immune-mediated hemolytic anemia with individually adjusted heparin dosing in dogs.
    Helmond SE; Polzin DJ; Armstrong PJ; Finke M; Smith SA
    J Vet Intern Med; 2010; 24(3):597-605. PubMed ID: 20384956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of human immunoglobulin in addition to glucocorticoids for the initial treatment of dogs with immune-mediated hemolytic anemia.
    Whelan MF; O'Toole TE; Chan DL; Rozanski EA; DeLaforcade AM; Crawford SL; Cotter SM
    J Vet Emerg Crit Care (San Antonio); 2009 Apr; 19(2):158-64. PubMed ID: 19691566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C
    Goggs R; Behling-Kelly E
    BMC Vet Res; 2019 Dec; 15(1):475. PubMed ID: 31888626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective study of unfractionated heparin therapy in dogs with primary immune-mediated hemolytic anemia.
    Breuhl EL; Moore G; Brooks MB; Scott-Moncrieff JC
    J Am Anim Hosp Assoc; 2009; 45(3):125-33. PubMed ID: 19411648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of canine idiopathic immune-mediated haemolytic anaemia with mycophenolate mofetil and glucocorticoids: 30 cases (2007 to 2011).
    Wang A; Smith JR; Creevy KE
    J Small Anim Pract; 2013 Aug; 54(8):399-404. PubMed ID: 23879827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prothrombotic mechanisms and anticoagulant therapy in dogs with immune-mediated hemolytic anemia.
    Kidd L; Mackman N
    J Vet Emerg Crit Care (San Antonio); 2013; 23(1):3-13. PubMed ID: 23356703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Point-of-care global coagulation assay parameters in normal dogs and dogs with primary immune-mediated hemolytic anemia.
    Dionne TL; Ishak AM; Cochran LA
    J Vet Emerg Crit Care (San Antonio); 2023 Jan; 33(1):81-90. PubMed ID: 36453474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppressive therapy for canine immune-mediated hemolytic anemia.
    Al-Ghazlat S
    Compend Contin Educ Vet; 2009 Jan; 31(1):33-41, 44; quiz 44. PubMed ID: 19241356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of prognostic factors, survival rates, and treatment protocols for immune-mediated hemolytic anemia in dogs: 151 cases (1993-2002).
    Weinkle TK; Center SA; Randolph JF; Warner KL; Barr SC; Erb HN
    J Am Vet Med Assoc; 2005 Jun; 226(11):1869-80. PubMed ID: 15934255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of idiopathic immune-mediated hemolytic anemia with mycophenolate mofetil in five dogs.
    West LD; Hart JR
    J Vet Emerg Crit Care (San Antonio); 2014; 24(2):226-31. PubMed ID: 24251650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of high-dose immunoglobulin M-enriched human immunoglobulin in dogs with immune-mediated hemolytic anemia.
    Bestwick JP; Sharman M; Whitley NT; Kisielewicz C; Skelly BJ; Tappin S; Kellett-Gregory L; Seth M
    J Vet Intern Med; 2022 Jan; 36(1):78-85. PubMed ID: 34779044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of evidence of a beneficial effect of azathioprine in dogs treated with prednisolone for idiopathic immune-mediated hemolytic anemia: a retrospective cohort study.
    Piek CJ; van Spil WE; Junius G; Dekker A
    BMC Vet Res; 2011 Apr; 7():15. PubMed ID: 21489250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary immune-mediated haemolytic anaemia: a retrospective long-term study in 61 dogs.
    Weingart C; Thielemann D; Kohn B
    Aust Vet J; 2019 Dec; 97(12):483-489. PubMed ID: 31454853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous administration of human immune globulin in dogs with immune-mediated hemolytic anemia.
    Scott-Moncrieff JC; Reagan WJ; Snyder PW; Glickman LT
    J Am Vet Med Assoc; 1997 Jun; 210(11):1623-7. PubMed ID: 9170090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective evaluation of rivaroxaban on haemostatic parameters in apparently healthy dogs.
    Evans LA; Tansey C; Wiebe M; Sloan CQ; Patlogar JE; Northcutt S; Murphy LA; Nakamura RK
    Vet Med Sci; 2019 Aug; 5(3):317-324. PubMed ID: 30848104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of immune-mediated hemolytic anemia in dogs with cyclophosphamide.
    Burgess K; Moore A; Rand W; Cotter SM
    J Vet Intern Med; 2000; 14(4):456-62. PubMed ID: 10935898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment with rivaroxaban and monitoring of coagulation profiles in two dogs with venous thromboembolism.
    Uchida M; Ohmi A; Fujiwara R; Fukushima K; Doi A; Azuma K; Tsujimoto H
    J Vet Med Sci; 2020 Sep; 82(9):1271-1276. PubMed ID: 32655095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.